Article
Mutations Affecting Cellular Levels of Cobalamin (Vitamin B12) Confer Tolerance to Bactericidal Antibiotics in Burkholderia cenocepacia.
Journal of microbiology and biotechnology - 28 Aug 2024
Lee Dongju, Park Jongwook, Kim Heenam Stanley
Abstract excerpt
The Burkholderia cepacia complex (Bcc) consists of opportunistic pathogens known to cause pneumonia in immunocompromised individuals, especially those with cystic fibrosis. Treating Bcc pneumonia is challenging due to the pathogens' high multidrug resistance. Therefore, inhalation therapy with tobramycin powder, which can achieve high antibiotic concentrations in the lungs, is a promising treatment option. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
